Mirum amends severance plan; expands CEO/NEO change-in-control benefits

Mirum Pharmaceuticals, Inc.

CEO Peetz: 12mo base salary + 12mo equity vesting (non-CIC); 24mo salary + 200% bonus + full vesting (CIC).
NEOs Longpre, Radovich, Vig: 9mo salary + 12mo vesting (non-CIC); 18mo salary + 150% bonus + full vesting (CIC).
Plan amendment removes automatic sunset provision; administrative changes made.
New participation agreements with each NEO reflect modified benefits.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.